Aflibercept in the Treatment of Metastatic Colorectal Cancer

Aflibercept in the Treatment of Metastatic Colorectal Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Tzu-Fei Wang, Albert Craig Lockhart
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-01-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://la-press.com/aflibercept-in-the-treatment-of-metastatic-colorectal-cancer-a2972

Similar Items

Aflibercept in the Treatment of Metastatic Colorectal Cancer
by: Tzu-Fei Wang, et al.
Published: (2012-01-01)

Ziv-aflibercept in metastatic colorectal cancer
by: Patel A, et al.
Published: (2013-12-01)

Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer
by: M.ª Echave, et al.
Published: (2014-07-01)

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
by: Guido Giordano, et al.
Published: (2014-01-01)

Aflibercept as a second-line therapy in metastatic colorectal cancer: A limited Indian experience
by: Govind Babu, et al.
Published: (2016-01-01)

Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment
by: Pu Ge, et al.
Published: (2022-08-01)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
by: Alessandro Ottaiano, et al.
Published: (2021-03-01)

Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer
by: Andre De Souza, et al.
Published: (2015-01-01)

Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers
by: Ana Fernández Montes, et al.
Published: (2019-03-01)

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2019-06-01)

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
by: Nieves Martínez-Lago, et al.
Published: (2022-01-01)

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
by: Nieves Martínez-Lago, et al.
Published: (2022-01-01)

Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)
by: Wafik S. El-Deiry, et al.
Published: (2019-03-01)

Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure
by: Shyam Aggarwal
Published: (2015-11-01)

Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer
by: Hironaga Satake, et al.
Published: (2020-11-01)

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer
by: John H. Strickler, et al.
Published: (2019-11-01)

Aflibercept as a treatment for malignant tumors
by: V. A. Ivanov, et al.
Published: (2022-03-01)

Antiangiogenesis therapy in the treatment of metastatic colorectal cancer
by: Axel Grothey MD, et al.
Published: (2012-11-01)

Recent developments in the treatment of metastatic colorectal cancer
by: Jonathan M. Loree, et al.
Published: (2017-08-01)

Oral drugs in the treatment of metastatic colorectal cancer
by: Pilar García-Alfonso, et al.
Published: (2021-04-01)

Long-Term Treatment of Metastatic Colorectal Cancer with Panitumumab
by: Miriam López-Gómez, et al.
Published: (2012-01-01)

Editorial: Molecular targets for the treatment of metastatic colorectal cancer
by: Alessandro Passardi, et al.
Published: (2023-12-01)

Optimizing the first-line treatment for metastatic colorectal cancer
by: Sara Cherri, et al.
Published: (2023-10-01)

Cetuximab for the first-line treatment of metastatic colorectal cancer
by: C Meads, et al.
Published: (2010-05-01)

Cetuximab for the first-line treatment of metastatic colorectal cancer
by: C Meads, et al.
Published: (2010-05-01)

Recent Advances in the Treatment of Metastatic Colorectal Cancer in Taiwan
by: Yu-Lin Lin, et al.
Published: (2011-01-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

Long-Term Treatment of Metastatic Colorectal Cancer with Panitumumab
by: Miriam López-Gómez, et al.
Published: (2012-02-01)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
by: Prashanth Rawla, et al.
Published: (2019-07-01)

Clinical observation of apatinib in the treatment of metastatic colorectal cancer
by: CHEN Zhu, LIU Yan, GAO Li-hua, CHEN Bu-you, TANG Ai-hua, LIU Jun
Published: (2021-12-01)

OPTIMIZATION OF METASTATIC COLORECTAL CANCER TREATMENT WITH RAS MUTATIONS
by: L. V. Bolotina
Published: (2015-02-01)

Role of antiangiogenic agents in the treatment of metastatic colorectal cancer
by: M. V. Zabelin, et al.
Published: (2018-05-01)

Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-03-01)

Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
by: Hiroshi Nakatsumi, et al.
Published: (2022-11-01)

Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
by: Hao Zhuang, et al.
Published: (2011-12-01)

Markers of metastatic colorectal cancer
by: Piotr Myśliwiec, et al.
Published: (2019-05-01)

Kras in metastatic colorectal cancer
by: A Wicki, et al.
Published: (2010-11-01)

Metastatic components in colorectal cancer
by: Marjan Hajimoradi Javarsiani, et al.
Published: (2019-01-01)

The Challenge of Metastatic Colorectal Cancer
by: Esther Uña Cidón
Published: (2010-01-01)

Expert consensus on maintenance treatment for metastatic colorectal cancer in China
by: Rui-Hua Xu, et al.
Published: (2016-01-01)